Revvity earnings were $237.6M for the trailing 12 months ending Jul 5, 2026, with -11.4% growth year over year. The latest RVTY earnings report on Jul 5, 2026 announced Q3 2026 earnings of $51.8M, up 27.3% from last quarter. For the last reported fiscal year 2025 ending Dec 28, 2025, RVTY reported annual earnings of $241.2M, with -10.8% growth.
RVTY past earnings growth
How has RVTY's earnings growth performed historically?
On RVTY's earnings call on Aug 4, 2026, Revvity (NYSE: RVTY) reported Q2 2026 earnings per share (EPS) of $0.47, up 2.17% year over year. Total RVTY earnings for the quarter were $51.82 million. In the same quarter last year, Revvity's earnings per share (EPS) was $0.46.
As of the last Revvity earnings report, Revvity is currently profitable. Revvity's net profit (also called net income) for the twelve months ending Jul 5, 2026 was $237.55 million, a 16.71% decrease year over year.
What was RVTY's earnings growth in the past year?
As of Revvity's earnings date in Aug 4, 2026, Revvity's earnings has grown -11.44% year over year. This is 22.99 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 11.55%. RVTY earnings in the past year totalled $237.55 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.